KRISTY CARTER: Open Payments
NPI 1487942421 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 43 payments from 9 companies in 2025. Trend: 2023 $826 · 2024 $1,017 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $202 |
| Axsome Therapeutics, Inc. | 11 | $181 |
| Lundbeck LLC | 9 | $146 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Lilly USA, LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, Auvelity, REXULTI, FANAPT, MOUNJARO, CAPLYTA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Qelbree.
Industry payments across KY — which companies pay providers there.
